Alternatively, upstream and downstream genes can be screened through gene libraries, especially key genes significantly related to ILF2, to explore the roles of these key genes and ILF2 in tumorigenesis and development to assess whether they can become proto-oncogenes, biomarkers, or anti-tumor therapeutic targets. Here, ILF2 is linked to neoplasm.